Broking Break: Your Top 5
A recap of the stories that grabbed your attention this week featuring LV and its secret discussions with insurers, Lloyd's on redundancies and Markerstudy's hints on buying.
5 – Markerstudy hints that buying and not selling is on agenda
Markerstudy group commercial director Martyn Holman has told Insurance Age that the suggestion that Markerstudy is up for sale is “unlikely to be true” and that the insurer is currently looking at a corporate restructure of its funding.
Last week the insurer declined to comment on reports that it was looking for a buyer.
Tackling the possibility of a deal Holman said: “It’s more about a
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.
You are currently unable to print this content. Please contact info@insuranceage.co.uk to find out more.
You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@insuranceage.co.uk
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@insuranceage.co.uk
Most read
- In Depth: Managing cyber risk in an ever-changing security landscape
- RSA confirms trading structure ahead of NIG integration
- In Depth: Cyber risk and AI – friend or foe?